Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemia.
Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemia. Leukemia. 2016 Apr; 30(4):947-50.
View in:
PubMed
subject areas
Acute Disease
Antineoplastic Agents
Gene Rearrangement
Humans
Imidazoles
Leukemia
Male
Middle Aged
Phenotype
Prognosis
Pyridazines
Receptor, Fibroblast Growth Factor, Type 1
authors with profiles
Daniel Arber